Comparison of intuitiveness, ease of use and preference among three prefilled, disposable growth hormone injection pens.

What Was Tested

Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this randomized controlled trial publication.

Adherence rates are often low, resulting in poor linear growth.

Who Took Part

By PubMed's age tags, the people studied were children and teenagers, both men and women.

Subjects aged ≥ 10 to < 18 years, with GH deficiency, Turner syndrome or short stature following small-for-gestational-age birth were randomized to intuitiveness (no instruction) or instruction groups.

How the Study Was Run

The researchers set it up as a randomized and crossover study.

The participants were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.

Each person switched between Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and the comparison at some point, usually with a gap in between.

Intuitiveness, ease-of-learning and overall preference were assessed using questionnaires.

What Was Measured

The subject headings attached to it are Disposable Equipment, Drug Delivery Systems, Human Growth Hormone, Injections, Patient Education as Topic, Surveys and Questionnaires and Turner Syndrome.

What This Means in Plain Language

The paper is a randomized and crossover study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2013 (Expert opinion on drug delivery), a journal based in England.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.